Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

SG&A Expenses

$19.35M

TTM · Period ending: Jun 30, 2026 · USD

LCTX SG&A Expenses

Latest reported$19.35Mperiod endingJun 30, 2026

Latest reported$19.35Mperiod endingJun 30, 2026

LCTX TTM SG&A Expenses ($700.00K → $19.35M)

TTM SG&A Expenses

High-resolution chart · PNG

LCTX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock SG&A Expenses — Trailing twelve months (TTM) (USD)
Period ending	SG&A Expenses (USD)
Jun 30, 2001	1,906,237
Mar 31, 2001	1,741,460
Dec 31, 2000	1,779,931
Sep 30, 2000	1,759,525
Jun 30, 2000	1,720,871
Mar 31, 2000	1,872,158
Dec 31, 1999	1,896,690
Sep 30, 1999	1,900,000
Jun 30, 1999	2,000,000
Mar 31, 1999	1,800,000
Sep 30, 1998	1,700,000
Jun 30, 1998	1,800,000
Mar 31, 1998	1,700,000
Dec 31, 1997	1,500,000
Sep 30, 1997	1,400,000
Jun 30, 1997	1,200,000
Mar 31, 1997	800,000
Dec 31, 1996	600,000
Sep 30, 1996	300,000
Jun 30, 1996	100,000
Mar 31, 1996	300,000
Dec 31, 1995	500,000
Sep 30, 1995	700,000
Jun 30, 1995	800,000
Mar 31, 1995	900,000
Dec 31, 1994	900,000
Sep 30, 1994	900,000
Jun 30, 1994	900,000
Mar 31, 1994	800,000
Dec 31, 1993	800,000
Sep 30, 1993	800,000
Jun 30, 1993	800,000
Mar 31, 1993	800,000
Dec 31, 1992	700,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.